Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

286
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
286
Testing a Claim about Population Proportion01:24

Testing a Claim about Population Proportion

3.4K
A complete procedure for testing a claim about a population proportion is provided here.
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
3.4K
Cancer Survival Analysis01:21

Cancer Survival Analysis

455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

554
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
554
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Sample Proportion and Population Proportion01:20

Sample Proportion and Population Proportion

5.7K
Collecting samples or responses from an entire population takes significant time and effort, so a researcher collects responses from only a sample of that population. Suppose a study needs to collect information about a specific mobile application. After sample collection, the researcher analyzes the data and discovers that most individuals in the sample use that specific mobile application. The sample proportion measures the number of individuals in a sample who either use or don't use the...
5.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

An Alternative Treatment Effect Measure for Time-to-Event Oncology Randomized Trials.

Cancers·2025
Same author

Robust Permutation Test of Intraclass Correlation Coefficient for Assessing Agreement.

Cancers·2025
Same author

Strategies to boost statistical efficiency in randomized oncology trials with primary time-to-event endpoints.

Statistical methods in medical research·2025
Same author

Consequences of the perivascular niche remodeling for tumoricidal T-cell trafficking into metastasis of ovarian cancer.

Research square·2024
Same author

The Cancer Moonshot Immuno-Oncology Translational Network at 5: accelerating cancer immunotherapies.

Journal of the National Cancer Institute·2023
Same author

Computational Optimization of Irradiance and Fluence for Interstitial Photodynamic Therapy Treatment of Patients with Malignant Central Airway Obstruction.

Cancers·2023

相关实验视频

Updated: Sep 11, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

376

优化单样样本测试对单个和双阶段瘤学试验中的比例进行优化.

Alan David Hutson1

  • 1Roswell Park Comprehensive Cancer Center, Department of Biostatistics and Bioinformatics, Elm and Carlton Streets, Buffalo, NY 14623, USA.

Cancers
|August 14, 2025
PubMed
概括

一种新的基于卷积的方法通过减少样本大小和成本来改善早期瘤学试验设计. 这种方法提供了精确的I型错误控制,使临床试验更加有效和灵活.

科学领域:

  • 生物统计学 生物统计学
  • 临床试验设计 临床试验设计
  • 瘤学研究研究

背景情况:

  • 由于疾病的成本或稀有性,II期瘤学试验经常使用单臂设计.
  • 传统的方法,如精确的二项式测试和西蒙的两阶段设计,往往是保守的,导致实际的I型错误率低于名义的alpha.
  • 这种保守性可能导致效率低下的试验设计,样本大小大于必要.

研究的目的:

  • 为早期瘤学试验设计开发一种新,灵活和高效的方法.
  • 为了保持精确的I型错误控制,同时提高设计效率.
  • 为现有的保守的试验设计方法提供实用的替代方案.

主要方法:

  • 提出了一个基于卷积的统计方法,它结合了二项式和模拟的正常分布.
  • 该方法为真实响应率 (π) 构建了一个不偏见的估计器.
  • 理论性质是衍生出来的,性能是根据一阶段和两阶段设计的传统精确测试来评估的.

主要成果:

  • 与标准方法相比,拟议的方法产生了更高效的试验设计,样本大小较小.
  • I型错误率是精确控制的,与名义alpha水平相匹配.
  • 引入了一种新的两阶段设计,并进行了临时徒劳性分析,证明了试验成本和持续时间的显著降低.
关键词:
临床试验临床试验临床试验临床试验临床试验准确的二项式测试扰动测试试验 扰动测试试验小样本的功率为小样本的功率.

更多相关视频

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.8K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

194

相关实验视频

Last Updated: Sep 11, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

376
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.8K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

194

结论:

  • 基于卷积的方法为早期瘤学试验设计提供了灵活和高效的替代方案.
  • 它有效地解决了传统方法的保守性.
  • 该方法提供了实用优势,包括减少资源利用和缩短研究时间表.